Literature DB >> 19856071

Community-acquired Acinetobacter baumannii meningitis in a previously healthy 14-month-old boy.

Takao Ozaki1, Naoko Nishimura, Yasuko Arakawa, Michio Suzuki, Atsushi Narita, Yasuto Yamamoto, Norio Koyama, Kazumasa Nakane, Naoko Yasuda, Keiji Funahashi.   

Abstract

We report a previously healthy 14-month-old boy who developed community-acquired Acinetobacter baumannii meningitis. He had no history of immunodeficiency, and was brought to Konan Kosei Hospital with a high fever and vomiting. His consciousness was clear, but neck stiffness was noted. Examination of the cerebrospinal fluid (CSF) revealed a cell count of 10 112/microl; protein, 216 mg/dl; and glucose, 9 mg/dl. A CSF test kit for bacterial capsular antigens (Pastorex Meningitis; Bio-Rad Laboratories) was positive for Haemophilus influenzae type b antigen. On day 3 of admission, the microorganism isolated by CSF culture was identified as A. baumannii. Therefore, his treatment was changed to meropenem hydrate from the initial therapy with panipenem/betamipron and ceftriaxone sodium hydrate. Because the CSF cell count remained elevated, meropenem hydrate was administered for a total of 19 days. The meningitis resolved with no sequelae.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19856071     DOI: 10.1007/s10156-009-0704-x

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  7 in total

1.  Multidrug-resistant Acinetobacter baumannii infection in children.

Authors:  Maia De Luca; Giulia Angelino; Francesca Ippolita Calò Carducci; Alessandra Martino; Stefania Bernardi; Paola Bernaschi; Michaela Carletti; Patrizia D'Argenio; Paolo Palma
Journal:  BMJ Case Rep       Date:  2011-08-11

2.  Phenotypic and molecular characterization of Acinetobacter clinical isolates obtained from inmates of California correctional facilities.

Authors:  Galarah D Golanbar; Christopher K Lam; Yi-Ming Chu; Carla Cueva; Stephanie W Tan; Isba Silva; H Howard Xu
Journal:  J Clin Microbiol       Date:  2011-03-30       Impact factor: 5.948

3.  Comparison of the virulence potential of Acinetobacter strains from clinical and environmental sources.

Authors:  Azam F Tayabali; Kathy C Nguyen; Philip S Shwed; Jennifer Crosthwait; Gordon Coleman; Verner L Seligy
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

4.  Iron-Regulated Phospholipase C Activity Contributes to the Cytolytic Activity and Virulence of Acinetobacter baumannii.

Authors:  Steven E Fiester; Brock A Arivett; Robert E Schmidt; Amber C Beckett; Tomislav Ticak; Mary V Carrier; Rajarshi Ghosh; Emily J Ohneck; Maeva L Metz; Marlo K Sellin Jeffries; Luis A Actis
Journal:  PLoS One       Date:  2016-11-22       Impact factor: 3.240

Review 5.  Convergence of Biofilm Formation and Antibiotic Resistance in Acinetobacter baumannii Infection.

Authors:  Subhasree Roy; Goutam Chowdhury; Asish K Mukhopadhyay; Shanta Dutta; Sulagna Basu
Journal:  Front Med (Lausanne)       Date:  2022-03-24

6.  The complete genome and phenome of a community-acquired Acinetobacter baumannii.

Authors:  Daniel N Farrugia; Liam D H Elbourne; Karl A Hassan; Bart A Eijkelkamp; Sasha G Tetu; Melissa H Brown; Bhumika S Shah; Anton Y Peleg; Bridget C Mabbutt; Ian T Paulsen
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

7.  Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA.

Authors:  Wayne A Warner; Shan N Kuang; Rina Hernandez; Melissa C Chong; Peter J Ewing; Jen Fleischer; Jia Meng; Sheena Chu; Dawn Terashita; L'Tanya English; Wangxue Chen; H Howard Xu
Journal:  BMC Infect Dis       Date:  2016-05-04       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.